RGEN
Repligen Corp : Canaccord Genuity Initiates Coverage With Hold Rating; Target Price $165
时间：2024-12-17 13:08:03 市场： 美股 综合
BioLife Solutions Appoints Tony J. Hunt to Its Board of Directors
时间：2024-12-16 21:11:21 市场： 美股 综合
Repligen Corp : UBS Raises Target Price to $190 From $185
时间：2024-11-14 00:32:01 市场： 美股 综合
Repligen Corp -Consolidated Financial Statements for Qtr Ended March 31, 2023 Through June 30, for Year Ended Dec 31, 2023 Require Restatement
时间：2024-09-19 04:25:44 市场： 美股 综合
Repligen Corp -Does Not Anticipate Restatement Will Have Any Impact on Co’s Overall Business Ops, Previously Reported Strategic Outlook
时间：2024-09-19 04:25:44 市场： 美股 综合
Repligen: Reaffirming Prior 2024 REV Guidance; Understated $6.6 Mln in H1 2024 to Be Added Incrementally, Thus Updating FY Range to $627 Mln-$642 Mln
时间：2024-09-19 04:25:44 市场： 美股 综合